Citations

Institution: Mayo Clinic Clear

Showing 10 of 108081 citations.

Trafficking defects inWASH-knockout fibroblasts originate from collapsed endosomal and lysosomal networks
Gomez, Timothy S., Gorman, Jacquelyn A. , Narvajas, Amaia Artal-Martinez de, Köenig, Alexander , Billadeau, Daniel D. , Narvajas, A A-M de

Molecular Biology of the Cell | June 21, 2012 | Volume: 23 | Issue: 16 | Pages: 3215-3228

10.1091/mbc.e12-02-0101 | PMID 22718907 Get It

The Arp2/3-activator Wiskott–Aldrich syndrome protein and Scar homologue (WASH) is suggested to regulate actin-dependent membrane scission during endosomal sorting, but its cellular roles have not been fully elucidated. To investigate WASH function, we generated tamoxifen-inducible WASH-knockout mouse embryonic fibroblasts (WASHout MEFs). Of interest, although EEA1+endosomes were enlarged, collapsed, and devoid of filamentous-actin and Arp2/3 in WASHout MEFs, we did not observe elongated membrane tubules emanating from these disorganized endomembranes. However, collapsed WASHout endosomes harbored segregated subdomains, containing either retromer cargo recognition complex–associated proteins or EEA1. In addition, we observed global collapse of LAMP1+lysosomes, with some lysosomal membrane domains associated with endosomes. Both epidermal growth factor receptor (EGFR) and transferrin receptor (TfnR) exhibited changes in steady-state cellular localization. EGFR was directed to the lysosomal compartment and exhibited reduced basal levels in WASHout MEFs. However, although TfnR was accumulated with collapsed endosomes, it recycled normally. Moreover, EGF stimulation led to efficient EGFR degradation within enlarged lysosomal structures. These results are consistent with the idea that discrete receptors differentially traffic via WASH-dependent and WASH-independent mechanisms and demonstrate that WASH-mediated F-actin is requisite for the integrity of both endosomal and lysosomal networks in mammalian cells.
External Quality Assessment of Platelet Disorder Investigations: Results of International Surveys on Diagnostic Tests for Dense Granule Deficiency and Platelet Aggregometry Interpretation
Hayward, Catherine P.M. , Moffat, Karen A. , Plumhoff, Elizabeth, Timleck, Marnie, Hoffman, Suzanne M., Spitzer, Ernie, Cott, Elizabeth Van, Meijer, Piet , Cott, Elizabeth M. Van

Seminars in Thrombosis and Hemostasis | June 21, 2012 | Volume: 38 | Issue: 06 | Pages: 622-631

10.1055/s-0032-1319767 | PMID 22718255 Get It

Targeted therapy of acute myeloid leukemia in 2012: towards individualized therapy
Foran, James M.

Hematology | June 21, 2012 | Volume: 17 | Issue: sup1 | Pages: s137-s140

10.1179/102453312x13336169156456 | PMID 22507802 Get It

JAK2 inhibitors and their impact in myeloproliferative neoplasms
Geyer, Holly L. , Tibes, Raoul , Mesa, Ruben A.

Hematology | June 21, 2012 | Volume: 17 | Issue: sup1 | Pages: s129-s132

10.1179/102453312x13336169156375 | PMID 22507800 Get It

Targeted therapy of multiple myeloma
Kyle, Robert A.

Hematology | June 21, 2012 | Volume: 17 | Issue: sup1 | Pages: s125-s128

10.1179/102453312x13336169156339 | PMID 22507799 Get It

Waldenström macroglobulinemia
Gertz, Morie A.

Hematology | June 21, 2012 | Volume: 17 | Issue: sup1 | Pages: s112-s116

10.1179/102453312x13336169156212 | PMID 22507796 Get It

Novel therapeutics in multiple myeloma
Stewart, A. Keith

Hematology | June 21, 2012 | Volume: 17 | Issue: sup1 | Pages: s105-s108

10.1179/102453312x13336169156131 | PMID 22507794 Get It

Frontline treatment of multiple myeloma
Fonseca, Rafaël , Fonseca, Rafael

Hematology | June 21, 2012 | Volume: 17 | Issue: sup1 | Pages: s101-s104

10.1179/102453312x13336169156096 | PMID 22507793 Get It

New developments in the management of diffuse large B-cell lymphoma
Habermann, Thomas M.

Hematology | June 21, 2012 | Volume: 17 | Issue: sup1 | Pages: s93-s97

10.1179/102453312x13336169156014 | PMID 22507791 Get It

The Development of Ascending Aortic Aneurysms After Elective Aortic Valve Replacement With St Jude Mechanical Valve Prosthesis in the Bicuspid Patient
Cohoon, Kevin P. , Foley, Jillian, Dieter, Robert S., Bakhos, Mamdouh, Schwartz, Jeffrey

Angiology | June 21, 2012 | Volume: 64 | Issue: 5 | Pages: 379-384

10.1177/0003319712450504 | PMID 22717597 Get It

The association between bicuspid aortic valve (BAV) and ascending aorta aneurysm is well described. Replacement of the ascending aorta is now being considered at 4.5 cm. We identified patients confirmed with BAV who underwent elective aortic valve replacement (AVR) with a mechanical St Jude Bioprosthesis from 1994 to 2000 who were ≤65 years of age at the time of surgery. Follow-up imaging was obtained by computed tomography (CT) angiography or echocardiography. A total of 225 patients who underwent AVR were identified; 60 patients had a BAV. Of all, 36 (60%) patients with BAV returned for follow-up imaging of their ascending aorta. Eight patients (22%) had diameters classifiable as aneurysmal (>4.5 cm) that developed within 9.6 ± 4.1 years from implant and requiring surgery. Of all, 7 patients (12%) died within 5.9 ± 2.5 years from their implant date. Lifelong serial monitoring of the ascending aorta for patients with BAV should be the standard of care.